Morphic Medical

Developer of RESET®, an endoscopically delivered device therapy that offers a non-surgical, alternative treatment for the treatment of #T2D and #obesity.

[Morphic Medical @MorphicMedical]

Metabolic dysfunction-associated steatotic liver disease affects ~60–75% of people with #T2D and is increasingly viewed as part of the broader cardiometabolic disease continuum. Integrated care and metabolic therapies may be key to improving outcomes.

[Morphic Medical @MorphicMedical]

We are excited to announce that Ian Howarth has joined us as Finance Manager! Ian’s experience in creating system solutions will play a key role in helping us build a robust management platform and enhance our finance capabilities.

Please join us in welcoming Ian to the team.

[MedEdge MEA @MedEdgeMEA]

🌟@MorphicMedical has appointed Terri Cooper to its Board of Directors, strengthening leadership as it advances metabolic health innovation.

#MorphicMedical #LifeSciences #MedicalDevices #LeadershipUpdate #MededgeMEA

[Morphic Medical @MorphicMedical]

#Morphic Medical is proud to sponsor the upcoming British Obesity & Metabolic Specialist Society Meeting June 10-12. Visit booth 11 to learn about RESET®, the first endoscopically delivered duodenal device therapy for the treatment of obesity. We look forward to seeing you there!

[Morphic Medical @MorphicMedical]

We're excited to be attending the upcoming ADA2026. If you're attending, we'd love to connect to share the latest advancements around RESET® therapy designed for the treatment of #T2D and #obesity. Contact us at [email protected] to schedule a meeting.
https://t.co/hgpMlJFIUU

[Morphic Medical @MorphicMedical]

RESET® provides patients living with obesity & type 2 diabetes with the only non-surgical, incision-free solution for immediate weight reduction and improvements in cardiometabolic disorders such as diabetes. Prof. Hayee of King’s College Hospital demonstrates placement below.

[Morphic Medical @MorphicMedical]

MorphicMedical will be attending ESGE in Milan. We'd love to connect with you to share the most recent developments regarding our revolutionary RESET® therapy for the treatment of #T2D and #obesity. Contact us at [email protected] to schedule a meeting. https://t.co/C0OG99GAns

[Morphic Medical @MorphicMedical]

Heading to Istanbul for the European Congress on Obesity (ECO 2026)? Don’t miss Dr. Ryder’s poster presentation showcasing new insights into metabolic health outcomes with RESET® across different ethnicities, based on a retrospective analysis from an international registry.

[Morphic Medical @MorphicMedical]

#MorphicMedical is looking forward to the Diabetes Kongress taking place in Berlin May 13-16 showcasing the RESET® System, designed for the treatment of obesity and related metabolic conditions!
Please contact us at [email protected], if you would like to schedule a meeting.

[Morphic Medical @MorphicMedical]

As we celebrate mothers this month, note that women bear a higher obesity burden: 18.5% vs. 14% of men (Obesity Evidence Hub, 2025). Menopause-driven weight gain raises risks for T2D & heart disease. New tools like #RESET therapy may help support sustainable weight loss.

[Morphic Medical @MorphicMedical]

Morphic Medical is excited to attend the upcoming ECO 2026 Conference, taking place May 12-15 in Instanbul.
If you’re attending, stop by Booth #2 to learn about the RESET® System, designed for the treatment of obesity and related metabolic conditions!

https://t.co/4tSYo3Iyrs.

[Morphic Medical @MorphicMedical]

We are delighted to welcome @LaShoun_Sanders to #MorphicMedical as Clinical Trials Manager. Her expertise in leading clinical trials will be pivotal to gaining regulatory and country approvals in the continued commercialization of RESET® across the globe. Welcome to the team!

[Morphic Medical @MorphicMedical]

MorphicMedical will be attending #DDW2026 in Chicago. We'd love to connect with you to share the most recent developments regarding our revolutionary #RESET therapy for T2D and Obesity. Contact us at [email protected] to schedule a meeting. https://t.co/XYeX54eVbX

[Morphic Medical @MorphicMedical]

Heading to Miami Beach for the Frontiers in Endoscopic Surgery Course? Be sure to stop by the Morphic Medical booth to learn about RESET®, the only endoscopic solution for immediate weight reduction and improvements in cardiometabolic disorders such as diabetes. See you there!

[Morphic Medical @MorphicMedical]

#MorphicMedical is looking forward to Diabetes UK Professional Conference 2026 showcasing the RESET® System, designed for the treatment of obesity and related metabolic conditions! Be sure to come by to discover the latest data and learn about upcoming training opportunities.

[Morphic Medical @MorphicMedical]

PRESS RELEASE: Morphic® Medical Strengthens Board with Appointment of Healthcare Veteran Terri Cooper. To read the full press release, please use the following link: Morphic® Medical Strengthens Board with Appointment of Healthcare Veteran Terri Cooper

[Morphic Medical @MorphicMedical]

When medications aren’t enough and bariatric surgery is not an option, RESET® offers a new path forward for people living with obesity and T2D. To learn more, contact [email protected].

RESET® is approved for sale in the EU & UK and limited to Investigational Use Only in US.

[Morphic Medical @MorphicMedical]

We are delighted to welcome Evelyn Kile to #MorphicMedical as Sr. Manager, Regulatory Affairs.
Evelyn’s expertise will be instrumental in supporting regulatory compliance, product registrations, and approvals in the commercialization of #RESET® in countries around the globe.

[Morphic Medical @MorphicMedical]

Not every person living with obesity wants drugs or surgery… that is where RESET® comes in. To learn more visit https://t.co/imy4AntuXw.

RESET® is approved for sale in the EU and UK. In the Us, RESET® is limited to Investigational Use Only.

[Morphic Medical @MorphicMedical]

If you are attending #ATTD2026 in Barcelona, be sure to stop by and view the E-Poster authored by Dr. Iskander Idris on Wednesday from 7:00-21:00 in the exhibition area. Dr. Idris will be available during breaks to answer your questions.